AA
AMGN icon

Apriem Advisors’s Amgen AMGN Stock Holding History

Apriem Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$880K Hold
2,500
– – 0.08% 97
2025
Q4 		$818K Buy
2,500
+5
+0.2% +$1.59K 0.08% 100
2025
Q3 		$704K Buy
2,495
+5
+0.2% +$1.45K 0.07% 105
2025
Q2 		$695K Hold
2,490
– – 0.07% 98
2025
Q1 		$776K Sell
2,490
-126
-5% -$37.2K 0.09% 88
2024
Q4 		$682K Buy
2,616
+92
+4% +$27.3K 0.08% 91
2024
Q3 		$813K Hold
2,524
– – 0.1% 81
2024
Q2 		$789K Buy
2,524
+44
+2% +$12.9K 0.1% 81
2024
Q1 		$705K Buy
2,480
+25
+1% +$7.32K 0.09% 89
2023
Q4 		$707K Hold
2,455
– – 0.09% 80
2023
Q3 		$660K Hold
2,455
– – 0.1% 80
2023
Q2 		$545K Hold
2,455
– – 0.08% 88
2023
Q1 		$593K Sell
2,455
-60
-2% -$14.7K 0.1% 82
2022
Q4 		$661K Sell
2,515
-170
-6% -$45.6K 0.11% 80
2022
Q3 		$605K Hold
2,685
– – 0.11% 83
2022
Q2 		$653K Hold
2,685
– – 0.11% 76
2022
Q1 		$649K Sell
2,685
-100
-4% -$23K 0.1% 81
2021
Q4 		$627K Buy
2,785
+95
+4% +$20.1K 0.09% 85
2021
Q3 		$572K Buy
2,690
+80
+3% +$18.4K 0.08% 83
2021
Q2 		$636K Buy
2,610
+74
+3% +$18.2K 0.09% 79
2021
Q1 		$631K Buy
2,536
+13
+0.5% +$3.1K 0.1% 79
2020
Q4 		$580K Buy
2,523
+26
+1% +$5.99K 0.1% 69
2020
Q3 		$635K Sell
2,497
-168
-6% -$41.6K 0.12% 66
2020
Q2 		$629K Buy
2,665
+90
+3% +$20.5K 0.13% 65
2020
Q1 		$522K Buy
2,575
+23
+0.9% +$5.02K 0.13% 68
2019
Q4 		$615K Hold
2,552
– – 0.12% 67
2019
Q3 		$494K Buy
2,552
+193
+8% +$37K 0.11% 75
2019
Q2 		$435K Sell
2,359
-160
-6% -$28.6K 0.14% 84
2019
Q1 		$479K Buy
2,519
+35
+1% +$6.68K 0.13% 76
2018
Q4 		$484K Buy
2,484
+380
+18% +$74.1K 0.17% 71
2018
Q3 		$436K Hold
2,104
– – 0.1% 89
2018
Q2 		$388K Buy
2,104
+700
+50% +$124K 0.09% 86
2018
Q1 		$239K Buy
+1,404
New +$258K 0.06% 113
2017
Q4 		– Sell
-1,119
Closed -$209K – 133
2017
Q3 		$209K Sell
1,119
-82
-7% -$14.5K 0.05% 124
2017
Q2 		$207K Buy
1,201
+2
+0.2% +$325 0.05% 125
2017
Q1 		$197K Buy
1,199
+517
+76% +$85.9K 0.05% 125
2016
Q4 		$100K Sell
682
-98
-13% -$14.7K 0.03% 168
2016
Q3 		$130K Hold
780
– – 0.04% 139
2016
Q2 		$119K Sell
780
-22
-3% -$3.42K 0.04% 151
2016
Q1 		$120K Sell
802
-378
-32% -$56.2K 0.05% 132
2015
Q4 		$192K Hold
1,180
– – 0.07% 93
2015
Q3 		$163K Buy
1,180
+180
+18% +$28.4K 0.06% 104
2015
Q2 		$154K Sell
1,000
-168
-14% -$26.9K 0.05% 114
2015
Q1 		$187K Buy
1,168
+568
+95% +$89.5K 0.06% 105
2014
Q4 		$96K Hold
600
– – 0.04% 136
2014
Q3 		$84K Sell
600
-5,572
-90% -$727K 0.03% 155
2014
Q2 		$731K Hold
6,172
– – 0.28% 71
2014
Q1 		$761K Hold
6,172
– – 0.29% 73
2013
Q4 		$704K Hold
6,172
– – 0.28% 68
2013
Q3 		$691K Hold
6,172
– – 0.3% 65
2013
Q2 		$609K Buy
+6,172
New +$640K 0.3% 63

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Apriem Advisors's AMGN Position: Q1 2026 in Review

Apriem Advisors held its Amgen (AMGN) position steady in Q1 2026 at 2,500 shares worth $880K. The position accounts for 0.08% of the portfolio, ranked #97.

Apriem Advisors first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Apriem Advisors held 2,500 shares of Amgen worth $880K as of Q1 2026.
  • Apriem Advisors left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.08% of Apriem Advisors's portfolio in Q1 2026, its #97 holding.
  • Apriem Advisors first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Apriem Advisors's 13F filing for Q1 2026, filed 15 May 2026.